FDA — authorised 13 August 2009
- Application: NDA022117
- Marketing authorisation holder: ABBVIE
- Status: supplemented
🇺🇸 SAPHRIS in United States
FDA authorised SAPHRIS on 13 August 2009
Marketing authorisation
Other Psychiatry approved in United States
Frequently asked questions
Is SAPHRIS approved in United States?
Yes. FDA authorised it on 13 August 2009.
Who is the marketing authorisation holder for SAPHRIS in United States?
ABBVIE holds the US marketing authorisation.